一个特定于核的前-桃体通路及其神经递质受体分布:对抗抑郁药选择的影响
Li Xue1,2, Ting Wang1,3, Junneng Shao1,3
1School of Biological Sciences & Medical Engineering, Southeast University, Nanjing, 210096, China.
Molecular psychiatry
|February 26, 2026
概括
大型抑郁症 (MDD) 的治疗反应因大脑连接性而异. 额叶到中枢杏仁体白质路径预测了对选择性血清素再吸收抑制剂的反应,而不是对血清素-上腺素再吸收抑制剂的反应.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 医疗成像医学成像
背景情况:
- 杏仁体在抗抑郁药反应中的作用对于主要抑郁障碍 (MDD) 至关重要.
- 与抗抑郁药反应相关的杏仁体细分的解剖学和分子差异尚不清楚.
- 调查皮质-杏仁体白质 (WM) 连接性可能会在MDD中区分SSRI和SNRI治疗反应.
研究的目的:
- 为了确定核层次的皮质-杏仁体WM连接是否区分MDD患者对SSRI和SNRIs的反应.
- 阐明差异性治疗反应的分子基础.
- 探索连接学,分子架构和遗传学在抗抑郁药物的有效性中的相互作用.
主要方法:
- 扩散张力成像 (DTI) 和概率曲谱被用来分析106名MDD患者的皮质-杏仁体WM连接性.
- 基于皮层投影的K-模式聚类识别了杏仁体的细分.
- 分数异构 (FA) 值与SSRI和SNRI响应者之间的WM连接进行了比较;转录组和SNP分析验证了结果.
主要成果:
- 确定了额叶和中间杏仁核 (medialAMY) 之间的WM连接的显著差异,表明了药理倾向模式.
- 这种模式与血清素和上腺素系统相关,影响治疗选择.
- 发现SLC6A4中的遗传变异基于这种连接性来调解治疗倾向.
结论:
- 皮层-杏仁体WM连接,特别是涉及中介AMY,在MDD中区分SSRI和SNRI反应.
- 这一发现突出了个性化抗抑郁药选择的潜在生物标志物.
- 整合宏观,微观和遗传数据为MDD治疗提供了新的见解.
相关概念视频
Drugs Affecting Neurotransmitter Release or Uptake
1.7K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.7K
Antidepressant Drugs: MAOIs and Other Agents
1.0K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.0K
Antidepressant Drugs: Overview
1.7K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.7K
Neurotransmitters
2.9K
Neurotransmitters are essential chemical messengers within the nervous system, facilitating the communication between neurons. These chemical messengers, varying in function and effect, are critical for sustaining various aspects of neurological health and emotional well-being.
2.9K
Neurotransmitters
5.4K
Neurotransmitters play a crucial role in the communication between neurons in the autonomic nervous system. Neurons in the autonomic nervous system can be cholinergic or adrenergic depending on the neurotransmitters synthesized. Cholinergic neurons use acetylcholine as their primary neurotransmitter. This includes all the preganglionic fibers of the sympathetic and pre- and postganglionic fibers of the parasympathetic nervous systems. In addition, neurons of the somatic nervous system also use...
5.4K
Neurochemical Transmission: Sites of Drug Action
3.7K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
3.7K


